Corcept Therapeutics Inc. buy Canaccord Genuity Group Inc.
Start price
26.03.26
/
50%
€33.55
Target price
26.03.27
€95.16
Performance (%)
204.32%
Price
18.08.26
€102.10
Summary
This prediction is currently active. With a performance of 204.32% the BUY prediction by Canaccord_Genuity_Gr is a big success. This prediction currently runs until 26.03.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Corcept Therapeutics Inc. | 5.366% | 5.366% |
| iShares Core DAX® | -0.874% | 5.325% |
| iShares Nasdaq 100 | -0.381% | 1.979% |
| iShares Nikkei 225® | -1.676% | 1.952% |
| iShares S&P 500 | -0.655% | 2.069% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Corcept Therapeutics Inc. diskutieren
Corcept Therapeutics (CORT) had its price target raised by Canaccord Genuity Group Inc. from $100.00 to $110.00. They now have a "buy" rating on the stock.
Ratings data for CORT provided by MarketBeat
Stopped prediction by Canaccord_Genuity_Gr for Corcept Therapeutics Inc.
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€59.40
28.05.26
28.05.26
€116.49
28.05.27
28.05.27
71.89%
18.08.26
18.08.26
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€19.83
08.03.23
08.03.23
€30.31
08.03.24
08.03.24
7.94%
09.03.24
09.03.24